The planned study will enrol six to eight paediatric and adult patients with PSS in the US and Europe.
In what GSK says represents a potential way to transform treatment for patients with certain types of rectal cancer, the ...
The FDA has approved zidesamtinib for adults with locally advanced or metastatic ROS1-positive non-small cell lung cancer.Zidesamtinib (Jideytro, GSK) is designed to provide highly selective coverage ...
SHELTON, CT / ACCESS Newswire / July 13, 2026 / NanoViricides, Inc. (NYSE American:NNVC) (the "Company"), a clinical ...
Sickle cell disease remains a major public health challenge in India, particularly among tribal populations. According to ...
The FDA just approved a new drug for use in ER+/HER2- metastatic breast cancer, based on a large study led by Fred Hutch's Dr ...